Literature DB >> 18511742

A synthetic prostone activates apical chloride channels in A6 epithelial cells.

Hui Fang Bao1, Lian Liu, Julie Self, Billie Jeanne Duke, Ryuji Ueno, Douglas C Eaton.   

Abstract

The bicyclic fatty acid lubiprostone (formerly known as SPI-0211) activates two types of anion channels in A6 cells. Both channel types are rarely, if ever, observed in untreated cells. The first channel type was activated at low concentrations of lubiprostone (<100 nM) in >80% of cell-attached patches and had a unit conductance of approximately 3-4 pS. The second channel type required higher concentrations (>100 nM) of lubiprostone to activate, was observed in approximately 30% of patches, and had a unit conductance of 8-9 pS. The properties of the first type of channel were consistent with ClC-2 and the second with CFTR. ClC-2's unit current strongly inwardly rectified that could be best fit by models of the channel with multiple energy barrier and multiple anion binding sites in the conductance pore. The open probability and mean open time of ClC-2 was voltage dependent, decreasing dramatically as the patches were depolarized. The order of anion selectivity for ClC-2 was Cl > Br > NO(3) > I > SCN, where SCN is thiocyanate. ClC-2 was a "double-barreled" channel favoring even numbers of levels over odd numbers as if the channel protein had two conductance pathways that opened independently of one another. The channel could be, at least, partially blocked by glibenclamide. The properties of the channel in A6 cells were indistinguishable from ClC-2 channels stably transfected in HEK293 cells. CFTR in the patches had a selectivity of Cl > Br >> NO(3) congruent with SCN congruent with I. It outwardly rectified as expected for a single-site anion channel. Because of its properties, ClC-2 is uniquely suitable to promote anion secretion with little anion reabsorption. CFTR, on the other hand, could promote either reabsorption or secretion depending on the anion driving forces.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18511742      PMCID: PMC2519861          DOI: 10.1152/ajpgi.00366.2007

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  121 in total

1.  Basolateral ClC-2 chloride channels in surface colon epithelium: regulation by a direct effect of intracellular chloride.

Authors:  Marcelo Catalán; María Isabel Niemeyer; L Pablo Cid; Francisco V Sepúlveda
Journal:  Gastroenterology       Date:  2004-04       Impact factor: 22.682

Review 2.  Disinhibitory pathways for control of sodium transport: regulation of ENaC by SGK1 and GILZ.

Authors:  Vivek Bhalla; Rama Soundararajan; Alan C Pao; Hongyan Li; David Pearce
Journal:  Am J Physiol Renal Physiol       Date:  2006-05-23

3.  Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing.

Authors:  Xiaoming Liu; Qinshi Jiang; S Gary Mansfield; M Puttaraju; Yulong Zhang; Weihong Zhou; Jonathan A Cohn; Mariano A Garcia-Blanco; Lloyd G Mitchell; John F Engelhardt
Journal:  Nat Biotechnol       Date:  2002-01       Impact factor: 54.908

4.  2 barrier-1 site pore: an interactive spreadsheet model for two permeating ions.

Authors:  M K Mansoura; D C Dawson
Journal:  Comput Biol Med       Date:  1998-05       Impact factor: 4.589

5.  Interferon-gamma regulates ClC-2 chloride channel in lung epithelial cells.

Authors:  Shijian Chu; Carol J Blaisdell; Penelope Bamford; Thomas J Ferro
Journal:  Biochem Biophys Res Commun       Date:  2004-11-05       Impact factor: 3.575

6.  S-adenosyl-L-homocysteine hydrolase regulates aldosterone-induced Na+ transport.

Authors:  J D Stockand; N F Al-Baldawi; O K Al-Khalili; R T Worrell; D C Eaton
Journal:  J Biol Chem       Date:  1999-02-05       Impact factor: 5.157

7.  Cloning and expression of a cDNA for the human prostanoid IP receptor.

Authors:  Y Boie; T H Rushmore; A Darmon-Goodwin; R Grygorczyk; D M Slipetz; K M Metters; M Abramovitz
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

8.  The two nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) have distinct functions in controlling channel activity.

Authors:  M R Carson; S M Travis; M J Welsh
Journal:  J Biol Chem       Date:  1995-01-27       Impact factor: 5.157

9.  SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents.

Authors:  John Cuppoletti; Danuta H Malinowska; Kirti P Tewari; Qiu-Ju Li; Ann M Sherry; Myra L Patchen; Ryuji Ueno
Journal:  Am J Physiol Cell Physiol       Date:  2004-06-22       Impact factor: 4.249

Review 10.  Permeation through the CFTR chloride channel.

Authors:  N A McCarty
Journal:  J Exp Biol       Date:  2000-07       Impact factor: 3.312

View more
  40 in total

Review 1.  Lubiprostone in constipation: clinical evidence and place in therapy.

Authors:  Nicholas Wilson; Ron Schey
Journal:  Ther Adv Chronic Dis       Date:  2015-03       Impact factor: 5.091

2.  Lubiprostone reverses the inhibitory action of morphine on mucosal secretion in human small intestine.

Authors:  Xiaohong Sun; Xiyu Wang; Guo-Du Wang; Yun Xia; Sumei Liu; Meihua Qu; Bradley J Needleman; Dean J Mikami; W Scott Melvin; Laura M Bohn; Ryuji Ueno; Jackie D Wood
Journal:  Dig Dis Sci       Date:  2010-12-23       Impact factor: 3.199

Review 3.  Chloride channels as drug targets.

Authors:  Alan S Verkman; Luis J V Galietta
Journal:  Nat Rev Drug Discov       Date:  2008-01-19       Impact factor: 84.694

4.  Lubiprostone activates non-CFTR-dependent respiratory epithelial chloride secretion in cystic fibrosis mice.

Authors:  Kelvin D MacDonald; Karen R McKenzie; Mark J Henderson; Charles E Hawkins; Neeraj Vij; Pamela L Zeitlin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-09-19       Impact factor: 5.464

5.  May the truth be with you: lubiprostone as EP receptor agonist/ClC-2 internalizing "inhibitor".

Authors:  Yasutada Akiba; Jonathan D Kaunitz
Journal:  Dig Dis Sci       Date:  2012-11       Impact factor: 3.199

6.  Stimulation of mucosal secretion by lubiprostone (SPI-0211) in guinea pig small intestine and colon.

Authors:  Guijun Fei; Yu-Zhong Wang; Sumei Liu; Hong-Zhen Hu; Guo-Du Wang; Mei-Hua Qu; Xi-Yu Wang; Yun Xia; Xiaohong Sun; Laura M Bohn; Helen J Cooke; Jackie D Wood
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-29       Impact factor: 4.052

7.  Lubiprostone stimulates secretion from tracheal submucosal glands of sheep, pigs, and humans.

Authors:  N S Joo; J J Wine; A W Cuthbert
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-02-20       Impact factor: 5.464

8.  Lubiprostone decreases mouse colonic inner mucus layer thickness and alters intestinal microbiota.

Authors:  Mark W Musch; Yunwei Wang; Erika C Claud; Eugene B Chang
Journal:  Dig Dis Sci       Date:  2013-01-18       Impact factor: 3.199

9.  Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndrome.

Authors:  Tisha N Lunsford; Lucinda A Harris
Journal:  Int J Womens Health       Date:  2010-10-27

10.  Lubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype.

Authors:  Robert C De Lisle; Racquel Mueller; Eileen Roach
Journal:  BMC Gastroenterol       Date:  2010-09-15       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.